Zonguldak Karaelmas University, Faculty of Medicine, Department of Medical Microbiology, 67100 Zonguldak, Turkey.
Anaerobe. 2010 Oct;16(5):505-9. doi: 10.1016/j.anaerobe.2010.08.002. Epub 2010 Aug 13.
The aim of this study was to determine the prevalence of enterotoxigenic Bacteroides fragilis (ETBF) in the patients with diarrhea in our region and to assess the association between diarrhea and bft gene subtypes. The presence of ETBF and bft gene subtypes were investigated in 200 stool samples from patients with diarrhea, diagnosed as gastroenteritis, which were sent to Clinical Microbiology Laboratory at Zonguldak Karaelmas University, Training and Research Hospital and in 200 stool samples from age-matched healthy subjects between April 14, 2009 and October 28, 2009. Nested - polymerase chain reaction was used to detect the presence of bft gene directly from stool samples. The bft gene subtypes were determined by PCR in case of ETBF detection. The presence of bft gene was detected in 29 (15%) of patients and 27 (14%) of control group. bft-1 and bft-2 were found in 24 and five stool samples from 29 diarrheic patients with ETBF, respectively. Among 27 control patients with ETBF, bft-1 and bft-2 were found in 24 and three samples, respectively. No bft-3 subtypes were identified in our study. ETBF was found as a single pathogen in 9% of the patients with diarrhea, while there was an accompanying pathogen in 6% of the patients. The proportion of coinfection with another pathogen among ETBF positive patients was 38%. Cooccurance with ETBF was present in nine of 18 patients with Rotavirus and two of five patients with Entamoeba histolytica. In conclusion; there was no statistically significant difference between the prevalence of ETBF in diarrheal patients and that of the control group. When the patients and controls were compared for each age group, no statistically significant difference in ETBF rates was found. There was no significant difference between groups with respect to bft subtypes; bft-1 was identified as the most common subtype. The rate of coinfection of ETBF and Rotavirus was high.
本研究旨在确定本地区腹泻患者中产肠毒素脆弱拟杆菌(ETBF)的流行率,并评估腹泻与 bft 基因亚型之间的关系。我们从 2009 年 4 月 14 日至 10 月 28 日期间,在 200 例因胃肠炎而送往宗古尔达克卡拉艾米尔大学培训与研究医院临床微生物学实验室的腹泻患者粪便样本(诊断为胃肠炎)和 200 例年龄匹配的健康对照者的粪便样本中,应用巢式-聚合酶链反应(PCR)直接检测 bft 基因的存在。在检测到 ETBF 的情况下,通过 PCR 确定 bft 基因亚型。在 29 例腹泻患者(15%)和 27 例对照组中检测到 bft 基因的存在。在 29 例 ETBF 腹泻患者中,bft-1 和 bft-2 分别存在于 24 例和 5 例粪便样本中,在 27 例 ETBF 对照组中,bft-1 和 bft-2 分别存在于 24 例和 3 例粪便样本中。在本研究中,未发现 bft-3 亚型。ETBF 作为单一病原体存在于 9%的腹泻患者中,而在 6%的患者中存在伴随病原体。在 ETBF 阳性患者中,与另一种病原体共同感染的比例为 38%。在 18 例轮状病毒阳性患者中有 9 例和 5 例溶组织内阿米巴阳性患者中有 2 例同时存在 ETBF。总之,在腹泻患者和对照组中,ETBF 的流行率无统计学差异。当按年龄组比较患者和对照组时,ETBF 率无统计学差异。各组之间 bft 亚型无显著差异;bft-1 是最常见的亚型。ETBF 与轮状病毒的合并感染率较高。